US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.
What's Going On With Ginkgo Bioworks Stock This Week? Ginkgo Bioworks Holdings Inc (
NYSE:DNA ) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today The company is forging ahead with next-generation drug development solutions.
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable and accessible tools for researchers.
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why Ginkgo Bioworks Holdings Inc (
NYSE:DNA ) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud.
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock The risks may resolve in a year or so but seizing the opportunities will take longer.
This 1 AI Stock Could Revolutionize Biotech and Pharma The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024 DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money? Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see.
7 Sorry Biotech Stocks Set to Make Investors Sad Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up.
DNA Stock: Ginkgo Bioworks Announces New Collaboration Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges.
